poliomyelitis

Documents about poliomyelitis

• Effect of Lactoferrin on Polio Seroconversion#18679ClinicalTrials.gov
• An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses#28407ClinicalTrials.gov
• Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Months#67664ClinicalTrials.gov
• Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine#121425ClinicalTrials.gov
• IPV Clinical Trial - The Gambia#332797ClinicalTrials.gov
• Duration of IPV Priming and Antibody Decay#332806ClinicalTrials.gov
• A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults#343700ClinicalTrials.gov
• Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea#343702ClinicalTrials.gov
• Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines#346974ClinicalTrials.gov
• Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine#353342ClinicalTrials.gov
• Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine#356517ClinicalTrials.gov
• Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants#363650ClinicalTrials.gov

Related topics